Clinical trial

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

NCT01976169

Study summary

ClinicalTrials.gov

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention PD-0332991 and T-DM1 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-01-24

PhasePHASE1

Conditions

Advanced Breast Cancerunresolved

Interventions

PD-0332991 and T-DM1DRUG

Sponsors & collaborators

University of Texas Southwestern Medical Centerlead sponsor

Pfizercollaborator

University of Pennsylvaniacollaborator

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01976169 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.